Hepatitis: Screening and Testing Methods

The development of serological tests for the identification of a counteracting agent to this newly discovered illness has been spurred by the disclosure of hepatitis infection (HV). Intravenous drug users, hemodialysis patients, hemophiliacs, and blood transfusion recipients are among the groups most seriously at risk of becoming infected with HV. The prevalence of post-transfusion hepatitis has significantly decreased because of screening blood donors for HV antagonists. One of the main problems with HV illness is the progression of chronic hepatitis, which can lead to cirrhosis and hepatocellular cancer in 50–60% of cases

 

    Related Conference of Hepatitis: Screening and Testing Methods

    July 17-18, 2023

    17th World Congress on Gastroenterology -Therapeutics & Hepatology

    Zurich, Switzerland
    July 18-19, 2023

    2nd International Conference on Gastroenterology and Liver

    Amsterdam, Netherlands
    July 26-27, 2023

    11th International Conference on Hepatitis & Liver Diseases

    Singapore City, Singapore
    August 07-08, 2023

    8th International Conference on Digestive and Metabolic Diseases

    Paris, France
    August 21-22, 2023

    23rd International Conference on Gastroenterology and Hepatology

    Frankfurt, Germany
    August 23-24, 2023

    29th World Conference on Gastroenterology & Hepatology

    Toronto, Canada
    September 21-22, 2023

    5th International Conference on Gastroenterology and Liver Diseases

    Paris, France
    November 13-14, 2023

    22nd World Congress on Gastrointestinal Cancer

    Dublin, Ireland
    November 29-30, 2023

    12th World Gastro Summit

    Amsterdam, Netherlands
    May 20-21, 2024

    24th International Conference on Gastroenterology and Hepatology

    Prague, Czech Republic

    Hepatitis: Screening and Testing Methods Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in